Virological outcomes of third-line antiretroviral therapy in a global context: a systematic reviews and meta-analysis

Tegene Atamenta Kitaw(Woldia University), Ribka Nigatu Haile(Woldia University), Befkad Derese Tilahun(Debre Tabor University), Getachew Tesfaw Walle(Woldia University), Abebe Merchaw Faris(Woldia University), Gizachew Yilak(Woldia University), Biruk Beletew Abate(Curtin University)

AIDS Research and Therapy

June 25, 2024

10.1186/s12981-024-00630-7

Cited by 4

Related Papers

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

|The Lancet|2025|386

The financial toxicity of cancer: unveiling global burden and risk factors – a systematic review and meta-analysis

|BMJ Global Health|2025|57

Global COVID-19 vaccine acceptance level and its determinants: an umbrella review

|BMC Public Health|2024|31

The global burden of erectile dysfunction and its associated risk factors in diabetic patients: an umbrella reviews

|BMC Public Health|2024|29

Prevalence, determinants, and complications of adolescent pregnancy: an umbrella review of systematic reviews and meta-analyses

|AJOG Global Reports|2025|14